PMID- 35360021
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220402
IS  - 2297-055X (Print)
IS  - 2297-055X (Electronic)
IS  - 2297-055X (Linking)
VI  - 9
DP  - 2022
TI  - Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and 
      Rationale for the Exacerbation of Cardiovascular Disease.
PG  - 861110
LID - 10.3389/fcvm.2022.861110 [doi]
LID - 861110
AB  - Depression is a common comorbidity of type 2 diabetes mellitus (T2DM). T2DM with 
      comorbid depression increases the risk of cardiovascular events and death. 
      Depression and T2DM and its macrovascular complications exhibited a two-way 
      relationship. Regarding treatment, antidepressants can affect the development of 
      T2DM and cardiovascular events, and hypoglycemic drugs can also affect the 
      development of depression and cardiovascular events. The combination of these two 
      types of medications may increase the risk of the first myocardial infarction. 
      Herein, we review the latest research progress in the exacerbation of 
      cardiovascular disease due to T2DM with comorbid depression and provide a 
      rationale and an outlook for the prevention and treatment of cardiovascular 
      disease in T2DM with comorbid depression.
CI  - Copyright (c) 2022 Zhu, Li, Luo, Cui, Liu and Liu.
FAU - Zhu, Mengmeng
AU  - Zhu M
AD  - National Clinical Research Centre for Chinese Medicine Cardiology, Xiyuan 
      Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
FAU - Li, Yiwen
AU  - Li Y
AD  - National Clinical Research Centre for Chinese Medicine Cardiology, Xiyuan 
      Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
FAU - Luo, Binyu
AU  - Luo B
AD  - National Clinical Research Centre for Chinese Medicine Cardiology, Xiyuan 
      Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
FAU - Cui, Jing
AU  - Cui J
AD  - National Clinical Research Centre for Chinese Medicine Cardiology, Xiyuan 
      Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
FAU - Liu, Yanfei
AU  - Liu Y
AD  - Second Department of Geriatrics, Xiyuan Hospital of China Academy of Chinese 
      Medical Sciences, Beijing, China.
FAU - Liu, Yue
AU  - Liu Y
AD  - National Clinical Research Centre for Chinese Medicine Cardiology, Xiyuan 
      Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220310
PL  - Switzerland
TA  - Front Cardiovasc Med
JT  - Frontiers in cardiovascular medicine
JID - 101653388
PMC - PMC8960118
OTO - NOTNLM
OT  - cardiovascular disease
OT  - clinical evidence
OT  - depression
OT  - outlook
OT  - type 2 diabetes mellitus (T2DM)
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/04/02 06:00
MHDA- 2022/04/02 06:01
PMCR- 2022/01/01
CRDT- 2022/04/01 05:16
PHST- 2022/01/24 00:00 [received]
PHST- 2022/02/07 00:00 [accepted]
PHST- 2022/04/01 05:16 [entrez]
PHST- 2022/04/02 06:00 [pubmed]
PHST- 2022/04/02 06:01 [medline]
PHST- 2022/01/01 00:00 [pmc-release]
AID - 10.3389/fcvm.2022.861110 [doi]
PST - epublish
SO  - Front Cardiovasc Med. 2022 Mar 10;9:861110. doi: 10.3389/fcvm.2022.861110. 
      eCollection 2022.